ENDRA Life Sciences
NDRA
5 hedge funds and large institutions have $1.53M invested in ENDRA Life Sciences in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
40% more capital invested
Capital invested by funds: $1.09M → $1.53M (+$436K)
0% less ownership
Funds ownership: 0% → 0% (-0%)
29% less funds holding
Funds holding: 7 → 5 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Creative Planning
Overland Park,
Kansas
|
-$48K |
| 2 |
IAM
ICM Asset Management
Spokane,
Washington
|
-$37.2K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$37.2K |
| 4 |
VF
Virtu Financial
New York
|
-$30K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IAM
1
ICM Asset Management
Spokane,
Washington
| $1.11M | -$37.2K | -1 | -5% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $164K | -$37.2K | -1 | -25% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $105K | – | – | – |
|
|
BRWA
4
B. Riley Wealth Advisors
Boca Raton,
Florida
| $39K | – | – | – |
|
|
WEC
5
Winslow Evans & Crocker
Boston,
Massachusetts
| $34K | – | – | – |
|
6
Northern Trust
Chicago,
Illinois
| $27K | – | – | – |
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $21K | – | – | – |
|
|
VWM
8
Vigilare Wealth Management
Scottsdale,
Arizona
| $15K | – | – | – |
|
9
Royal Bank of Canada
Toronto,
Ontario, Canada
| $5K | – | – | – |
|
10
Morgan Stanley
New York
| $4K | – | – | – |
|
|
11
Creative Planning
Overland Park,
Kansas
| – | -$48K | -1 | Closed |
|
|
VF
12
Virtu Financial
New York
| – | -$30K | -1 | Closed |
|
|
13
Victory Capital Management
San Antonio,
Texas
| – | -$1K | – | – |
|
NDRA Hedge Fund Activity: Q4 2019 in Review
5 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q4 2019, worth a combined $1.53M — up 40% from $1.09M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NDRA and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Creative Planning, exiting entirely with an estimated $48K sold.
- 5 institutional investors held ENDRA Life Sciences (NDRA) as of Q4 2019, down from 7 in Q3 2019.
- Funds reported $1.53M of ENDRA Life Sciences stock for Q4 2019, up 40% quarter-over-quarter.
- 0 funds opened new ENDRA Life Sciences positions in Q4 2019 and 2 closed out, a net change of -2 holders.
- The largest ENDRA Life Sciences seller in Q4 2019 was Creative Planning, an estimated $48K sold.
Based on aggregated 13F filings for Q4 2019.